Surgery-First Versus Neoadjuvant Chemotherapy in Stage I (cT1c) Triple-Negative Breast Cancer: A Critical Reappraisal

Study limitation reported by the research below: “The study design tag ('Comparative Study') is a best guess based on the title phrasing 'Surgery-First Versus Neoadjuvant Chemotherapy'; the exact methodology (retrospective cohort, RCT, meta-analysis, etc.) is unconfirmed.”